Details of the Drug

General Information of Drug (ID: DMNZJAE)

Drug Name

AAV-CNGA3

Indication

Disease Entry	ICD 11	Status	REF
Achromatopsia	9B70	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Gene therapy

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Cyclic nucleotide-gated channel alpha-3 (CNGA3)	TTW0QOV	CNGA3_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT03758404) Gene Therapy for Achromatopsia (CNGA3) (CNGA3). U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of MeiraGTx.